Adam Vogel

PhD - CEO / Chief Science Officer

Adam Vogel PhD is the Chief Science Officer and Founder of Redenlab. He currently serves as CEO and leads Redenlab’s speech testing and analysis work. Adam has an international track record for developing speech tests to guide decisions about brain function and quality of life in clinical medicine and drug development.

Adam holds a PhD in behavioural neuroscience from The University of Melbourne and degrees in psychology and speech science from the University of Queensland, Australia. He is also Director of the Centre for Neuroscience of Speech at The University of Melbourne, Australia and maintains strong research alliances with the leading clinical centres in Australia, Europe and the United States.